{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:45:37Z","timestamp":1782215137658,"version":"3.54.5"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"DOI":"10.1093\/eurheartj\/ehag215","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:44:00Z","timestamp":1773924240000},"page":"3149-3151","source":"Crossref","is-referenced-by-count":1,"title":["The dual face of lamin A\/C cardiomyopathy: risk prediction of heart failure and arrhythmias"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-7803","authenticated-orcid":false,"given":"Stephane","family":"Heymans","sequence":"first","affiliation":[{"name":"Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases , Universiteitssingel 50, Maastricht 6229 ER ,","place":["The Netherlands"]},{"name":"Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven , Herestraat 49, Leuven 3000 ,","place":["Belgium"]},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2026062219565096300_ehag215-B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"2026062219565096300_ehag215-B2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"key":"2026062219565096300_ehag215-B3","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1093\/eurheartj\/ehag104","article-title":"Laminopathies: natural history and risk prediction of heart failure","volume":"47","author":"Charron","year":"2026","journal-title":"Eur Heart J"},{"key":"2026062219565096300_ehag215-B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12964-024-01546-5","article-title":"From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy","volume":"22","author":"Veltrop","year":"2024","journal-title":"Cell Commun Signal"},{"key":"2026062219565096300_ehag215-B5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/jcm9051443","article-title":"Can circulating cardiac biomarkers be helpful in the assessment of LMNA mutation carriers?","volume":"9","author":"Chmielewski","year":"2020","journal-title":"J Clin Med"},{"key":"2026062219565096300_ehag215-B6","doi-asserted-by":"publisher","first-page":"e011548","DOI":"10.1161\/CIRCHEARTFAILURE.123.011548","article-title":"REALM-DCM: a phase 3, multinational, randomized, placebo-controlled trial of ARRY-371797 in patients with symptomatic LMNA-related dilated cardiomyopathy","volume":"17","author":"Garcia-Pavia","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026062219565096300_ehag215-B7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"Authors\/Task Force Members:","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026062219565096300_ehag215-B8","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026062219565096300_ehag215-B9","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","article-title":"Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement","volume":"12","author":"Halliday","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026062219565096300_ehag215-B10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jcmg.2025.01.004","article-title":"The cardiovascular magnetic resonance phenotype of lamin heart disease","volume":"18","author":"Topriceanu","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026062219565096300_ehag215-B11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jcmg.2022.01.016","article-title":"Left atrial strain has superior prognostic value to ventricular function and delayed-enhancement in dilated cardiomyopathy","volume":"15","author":"Raafs","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026062219565096300_ehag215-B12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41525-021-00266-w","article-title":"Lamin A\/C missense variants: from discovery to functional validation","volume":"6","author":"Lazarte","year":"2021","journal-title":"NPJ Genom Med"},{"key":"2026062219565096300_ehag215-B13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/CIRCGEN.119.002853","article-title":"LMNA missense mutation causes nonsense-mediated mRNA decay and severe dilated cardiomyopathy","volume":"13","author":"Kato","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026062219565096300_ehag215-B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3516","article-title":"State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases","volume":"27","author":"Van Linthout","year":"2025","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/24\/3149\/68279467\/ehag215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/24\/3149\/68279467\/ehag215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:56:58Z","timestamp":1782172618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/24\/3149\/8677319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":14,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag215","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,21]]},"published":{"date-parts":[[2026,5,13]]}}}